IVF_INSPIRE IVF (IVF) fair value: what the stock is really worth
As of Oct 15, 2026: fair value of IVF_INSPIRE IVF THB 0.91, price THB 0.71, upside +28.2%, quality 38 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Inspire IVF Public Company Limited operates an infertility treatment center in Thailand.
Show moreShow less
It offers intrauterine insemination, preimplantation genetic testing, intracytoplasmic sperm injection, embryo transfer, fertility preservation, preventive and regenerative medicine, health checkup, and other infertility treatments.
The company provides obstetrics and gynecology examinations, consulting, and advice, as well as age management medicine, health regeneration, blood dialysis, and blood filtration services. Inspire IVF Public Company Limited was incorporated in 2018 and is based in Bangkok, Thailand.
Stock analysis
IVF_INSPIRE IVF (IVF) currently trades at 0.7100 THB, while our model-based Fair Value estimate is 0.9100 THB, implying the stock looks roughly 22.0% undervalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 88/100, which puts the data coverage at low.
Scenario range: 0.6000 THB (bear) to 1.14 THB (bull), the price of 0.7100 THB sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 38/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
IVF_INSPIRE IVF reported revenue of 61.9M THB in FY2025 versus 11.2M THB in FY2021, a compound +53.2%/yr. Reported net income was −17.4M THB in FY2025.
Key figures
Market cap 312M THB (≈ $9.3M) · P/S ratio 4.81 · EPS (TTM) −0.0300 THB · Dividend yield 3.4% · Net margin −28.1% · Return on equity −4.4% · Return on assets (EBIT) 5.0% · Operating margin −53.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 10 out of 100 (low confidence).
What moves the price
The share trades about 27% below its 52-week high and 31% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 20% fair-value upside, at 28%, IVF screens cheaper than that median.
Fair Value models
Bear0.6000 THBFair Value 0.9100 THBBull1.14 THB
Price 0.7100 THB · Upside +28.2%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.3/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−41.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.8%
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−61.1% (2021) → −40.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 245 stocks
Beats the industry median on 3/8 measures
Overall it trails its industry peers.
Valuation
Quality Score38 · Bottom 25%
Fair Value upside+30.0% · Above median
Profitability
Return on assets−2.9% · Bottom 25%
Net margin (12 months)−35.6% · Bottom 25%
Operating margin (12 months)−53.8% · Bottom 25%
Growth and dividend
Revenue growth−5.5% · Bottom 25%
Dividend yield (12 months)3.4% · Above median
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "IVF_INSPIRE IVF Fair Value". https://www.fairvalue-calculator.com/stock/IVF
Frequently asked questions
Is IVF_INSPIRE IVF (IVF) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of 0.9100 THB versus a price of 0.7100 THB, about +28% upside (undervalued).
What is the fair value of IVF?
Our model-based fair value for IVF_INSPIRE IVF is 0.9100 THB (as of Oct 3, 2026), built from audited fundamentals. The current price: 0.7100 THB.
What is the quality score of IVF?
IVF_INSPIRE IVF has a Quality Score of 38/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for IVF_INSPIRE IVF (IVF)?
Our model-based price target is the fair value of 0.9100 THB (as of Oct 3, 2026) from 1 valuation models. Cautious scenario 0.6000 THB, optimistic scenario 1.14 THB. It is a calculation from audited fundamentals, not an analyst target.
What is the IVF_INSPIRE IVF stock forecast for 2026?
Our models put fair value at 0.9100 THB, about +28% upside versus a price of 0.7100 THB (undervalued). Cautious scenario 0.6000 THB, optimistic scenario 1.14 THB. The calculation is refreshed regularly with new filings.
What is the revenue of IVF_INSPIRE IVF (IVF)?
IVF_INSPIRE IVF reported trailing-twelve-month revenue of about 65.0M THB (latest available figure, as of Oct 3, 2026).
Does IVF_INSPIRE IVF pay a dividend?
IVF_INSPIRE IVF currently shows a dividend yield of about 3.38% relative to its recent price (as of Oct 3, 2026).
What is the intrinsic value of IVF_INSPIRE IVF (IVF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For IVF_INSPIRE IVF it is 0.9100 THB per share (as of Oct 3, 2026), against a price of 0.7100 THB. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is IVF_INSPIRE IVF stock overvalued or undervalued in 2026?
As of Oct 3, 2026, IVF trades below its calculated fair value: price 0.7100 THB, fair value 0.9100 THB, a gap of about +28% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of IVF?
No. The price is what the market pays today (0.7100 THB); the fair value is what the company's own numbers justify (0.9100 THB). For IVF_INSPIRE IVF the two are 0.2000 THB per share apart. That gap is exactly why we show both numbers side by side.
How much is IVF_INSPIRE IVF worth?
The market values IVF_INSPIRE IVF at about 312M THB (market capitalisation, as of Oct 3, 2026). Per share that is 0.7100 THB; our models calculate a fair value of 0.9100 THB per share.
What do the bullish and bearish scenarios say about IVF?
Our models span a range for IVF_INSPIRE IVF: cautious scenario 0.6000 THB, base 0.9100 THB, optimistic 1.14 THB per share (as of Oct 3, 2026, price 0.7100 THB). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of IVF_INSPIRE IVF (IVF)?
Balance-sheet figures for IVF_INSPIRE IVF (as of Oct 3, 2026): return on equity −4.4%. They feed the Quality Score of 38/100, which measures business quality independently of the share price.
How far is IVF from its 52-week high?
IVF_INSPIRE IVF trades at 0.7100 THB, about 27% below its 52-week high of 0.9700 THB and 31% above the low of 0.5400 THB (as of Oct 15, 2026). Distance from the high says nothing about value: that is what the fair value of 0.9100 THB is for.
Which stocks are comparable to IVF_INSPIRE IVF?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, Tenet Healthcare Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is IVF_INSPIRE IVF stock attractive at the current price?
The data as of Oct 3, 2026: price 0.7100 THB, calculated fair value 0.9100 THB (+28%), Quality Score 38/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of IVF calculated?
We run IVF_INSPIRE IVF through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 0.9100 THB, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.7 % above its aggregate fair value. IVF_INSPIRE IVF currently trades 22 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of IVF_INSPIRE IVF (IVF)?
The closing price on Oct 15, 2026 was 0.7100 THB. Our model-based fair value is 0.9100 THB, about +28% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with IVF_INSPIRE IVF right now?
A fairly wide model range (0.6000 THB to 1.14 THB) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of IVF_INSPIRE IVF
How large is the market capitalisation of IVF_INSPIRE IVF (IVF)?
The market capitalisation of IVF_INSPIRE IVF is 312M THB (≈ $9.3M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of IVF_INSPIRE IVF (IVF)?
The price-to-sales ratio of IVF_INSPIRE IVF is 4.81 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of IVF_INSPIRE IVF (IVF)?
Earnings per share at IVF_INSPIRE IVF are −0.0300 THB. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of IVF_INSPIRE IVF (IVF)?
The dividend yield of IVF_INSPIRE IVF is 3.4%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of IVF_INSPIRE IVF (IVF)?
The net margin of IVF_INSPIRE IVF is −28.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of IVF_INSPIRE IVF (IVF)?
The return on equity (ROE) of IVF_INSPIRE IVF is −4.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of IVF_INSPIRE IVF (IVF)?
On an EBIT basis the return on assets of IVF_INSPIRE IVF is 5.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of IVF_INSPIRE IVF (IVF)?
The operating margin of IVF_INSPIRE IVF is −53.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at IVF_INSPIRE IVF (IVF)?
Revenue at IVF_INSPIRE IVF is growing −5.5% versus a year earlier (3y avg −0.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does IVF_INSPIRE IVF (IVF) generate?
The free cash flow of IVF_INSPIRE IVF is −13.9M THB (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does IVF_INSPIRE IVF (IVF) carry?
The net debt of IVF_INSPIRE IVF is 11.5M THB (fiscal year 2021). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch IVF_INSPIRE IVF in the live analysis
One click puts IVF_INSPIRE IVF on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener.
Thin data
Oct 3, 2026